VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Cardiovascular Events in Patients with Compromised Renal Function at Baseline in Prespecified and Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Society of Nephrology GlobeNewsWire • 10/26/20
U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately Elevated Triglyceride (TG) Levels Despite Well-Controlled Low-Density Lipoprotein (LDL)-CholesterolGlobeNewsWire • 10/23/20
Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020GlobeNewsWire • 10/19/20
The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOsBenzinga • 10/16/20
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Intervention (PCI) in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at Transcatheter Cardiovascular Therapeutics (TCTGlobeNewsWire • 10/15/20
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?Zacks Investment Research • 10/09/20
Latest Research Evaluating VASCEPA® (Icosapent Ethyl) Mechanisms of Action Presented at European Atherosclerosis Society (EAS) Congress 2020GlobeNewsWire • 10/05/20
Amarin Corporation plc (AMRN) CEO John Thero Presents at Cantor Virtual Global Healthcare Conference (Transcript)Seeking Alpha • 09/16/20
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/02/20
Amarin Supports Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Persistent Cardiovascular Risk Presented at ESC Congress 2020, the Annual Meeting of the European Society of CardiologyGlobeNewsWire • 09/01/20
VASCEPA® (Icosapent Ethyl) Reported to Significantly Reduce Coronary Plaque in EVAPORATE Study Final Results Presented at ESC Congress 2020GlobeNewsWire • 08/29/20